Latest filing published 01 Sept 2022 for Lytix Biopharma ASA, €29k.
Filing timeline
BuySaleGert W. Munthe: trading record in brief
All filings by Gert W. Munthe on record concern Lytix Biopharma ASA. In total, 2 filings cover trades dated from 27 August 2022 to 1 September 2022.
No open-market sale appears; the market trades are 2 purchases worth €132k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
The record was last updated on 1 September 2022 with an open-market purchase (€29k) in Lytix Biopharma ASA. Every figure here comes from the filings published by Oslo Børs and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Gert W. Munthe
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 33,519 shares@ NOK 8.565621.7% of flowShareMERKOSLO:570389Canonical exit: 30 Nov 2022 (T+90)
- 125,000 shares@ NOK 7.971478.3% of flowShareMERKOSLO:569902Canonical exit: 25 Nov 2022 (T+90)
2 of 2 declarations